In brief
Public health experts warn that President Trump's withdrawal from the World Health Organization (WHO) could severely impact not just international health initiatives but also domestic healthcare in the United States. The potential loss of crucial data on outbreaks, such as mpox and diseases like malaria and measles, may put American lives at risk. Moreover, the move may inadvertently bolster the influence of countries like China and Russia in shaping a global health agenda, leaving the U.S. less involved in worldwide health policies that ultimately affect its citizens.
The WHO, with a budget of $6.8 billion for 2024-2025—a fraction of the funding of individual state health departments—plays a vital role in compiling international health standards, monitoring diseases, and outlining public health strategies. Its work directly affects American healthcare through systems that inform healthcare providers and insurance companies, such as the International Classification of Diseases. Experts stress that, while the U.S. may possess substantial resources, global health issues require collaborative efforts. Disengagement from the WHO isn't just a loss for global health; it could dismantle frameworks that keep Americans informed about health threats and coordinated efforts for disease prevention. The withdrawal process is set to take a year to finalize, yet it has already instigated significant budget cuts within the organization. Access to WHO resources and guidelines may diminish before the official exit, prompting concerns about the implications for health initiatives that benefit Americans. "As a superpower, there's a reason we established a global health entity post-World War," emphasizes Loyce Pace, former assistant secretary of health. “The challenges we face today cannot be tackled in isolation.” The decision encapsulates broader questions about the U.S.'s commitment to global health partnerships and the potential consequences for public health both at home and abroad.
